FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017552485> ?p ?o ?g. }

• W2017552485 endingPage "991" @default.
• W2017552485 startingPage "983" @default.
• W2017552485 abstract "Background Patients are at risk of second malignancies (SM) after treatment for Ewing sarcoma family of tumours (ESFT). Methods We performed a retrospective review of 237 patients with ESFT treated at our institution from September 1979 through to February 2004. Cumulative incidence (CI) of SM by the type of malignancy and treatment was estimated. Results Twelve patients with SM were identified. Secondary leukaemia (SL) developed in 8 patients (2 ALL, 6 MDS/AML), a median 2.6 years (range 1.4–19.6 years) after diagnosis of ESFT. Four patients had secondary solid tumours, a median 8.0 years (range 7.4–9.4 years) after the ESFT diagnosis. Five- and 10-year estimates of the CI of SM were 3.0 ± 1.1% and 4.7 ± 1.5%, respectively. Patients treated on recent protocols with higher cumulative doses or an increased dose intensity of alkylators and epipodophyllotoxins and the use of G-CSF had a higher estimated CI of SL than those in earlier studies (5-year CI 6.4 ± 2.4% versus 0.0 ± 0.0%, respectively, P = 0.004). Conclusions Patients with ESFT are at risk for SM after treatment. The cumulative incidence of SM is higher with the current treatment protocols and may be related to the intensification of chemotherapeutic agents." @default.
• W2017552485 created "2016-06-24" @default.
• W2017552485 creator A5028462415 @default.
• W2017552485 creator A5045180889 @default.
• W2017552485 creator A5048122275 @default.
• W2017552485 creator A5048193615 @default.
• W2017552485 creator A5053244337 @default.
• W2017552485 date "2008-05-01" @default.
• W2017552485 modified "2023-09-23" @default.
• W2017552485 title "Second cancers in patients with the Ewing sarcoma family of tumours" @default.
• W2017552485 cites W1524039104 @default.
• W2017552485 cites W1719540238 @default.
• W2017552485 cites W1772956500 @default.
• W2017552485 cites W1796305773 @default.
• W2017552485 cites W1829759922 @default.
• W2017552485 cites W1843902156 @default.
• W2017552485 cites W1848892094 @default.
• W2017552485 cites W1855359775 @default.
• W2017552485 cites W1856633708 @default.
• W2017552485 cites W1906676875 @default.
• W2017552485 cites W1910981723 @default.
• W2017552485 cites W1967605972 @default.
• W2017552485 cites W1993931486 @default.
• W2017552485 cites W1996683133 @default.
• W2017552485 cites W1999218190 @default.
• W2017552485 cites W1999603200 @default.
• W2017552485 cites W2001909201 @default.
• W2017552485 cites W2007532842 @default.
• W2017552485 cites W2016644651 @default.
• W2017552485 cites W2022645679 @default.
• W2017552485 cites W2038252730 @default.
• W2017552485 cites W2041215111 @default.
• W2017552485 cites W2045188452 @default.
• W2017552485 cites W2053278247 @default.
• W2017552485 cites W2057250476 @default.
• W2017552485 cites W2066061915 @default.
• W2017552485 cites W2071930830 @default.
• W2017552485 cites W2072315137 @default.
• W2017552485 cites W2073140442 @default.
• W2017552485 cites W2074812750 @default.
• W2017552485 cites W2077671452 @default.
• W2017552485 cites W2080006818 @default.
• W2017552485 cites W2082876519 @default.
• W2017552485 cites W2090502412 @default.
• W2017552485 cites W2092937803 @default.
• W2017552485 cites W2093507211 @default.
• W2017552485 cites W2103460784 @default.
• W2017552485 cites W2106789493 @default.
• W2017552485 cites W2111120253 @default.
• W2017552485 cites W2126964833 @default.
• W2017552485 cites W2141220710 @default.
• W2017552485 cites W2148583847 @default.
• W2017552485 cites W2154887526 @default.
• W2017552485 cites W2166229395 @default.
• W2017552485 cites W2180449943 @default.
• W2017552485 cites W2319393554 @default.
• W2017552485 cites W2325621095 @default.
• W2017552485 cites W2395081172 @default.
• W2017552485 cites W2465708327 @default.
• W2017552485 cites W3143166964 @default.
• W2017552485 doi "https://doi.org/10.1016/j.ejca.2008.02.027" @default.
• W2017552485 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2423466" @default.
• W2017552485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18353632" @default.
• W2017552485 hasPublicationYear "2008" @default.
• W2017552485 type Work @default.
• W2017552485 sameAs 2017552485 @default.
• W2017552485 citedByCount "56" @default.
• W2017552485 countsByYear W20175524852012 @default.
• W2017552485 countsByYear W20175524852013 @default.
• W2017552485 countsByYear W20175524852014 @default.
• W2017552485 countsByYear W20175524852015 @default.
• W2017552485 countsByYear W20175524852016 @default.
• W2017552485 countsByYear W20175524852017 @default.
• W2017552485 countsByYear W20175524852018 @default.
• W2017552485 countsByYear W20175524852019 @default.
• W2017552485 countsByYear W20175524852020 @default.
• W2017552485 countsByYear W20175524852021 @default.
• W2017552485 countsByYear W20175524852022 @default.
• W2017552485 crossrefType "journal-article" @default.
• W2017552485 hasAuthorship W2017552485A5028462415 @default.
• W2017552485 hasAuthorship W2017552485A5045180889 @default.
• W2017552485 hasAuthorship W2017552485A5048122275 @default.
• W2017552485 hasAuthorship W2017552485A5048193615 @default.
• W2017552485 hasAuthorship W2017552485A5053244337 @default.
• W2017552485 hasBestOaLocation W20175524852 @default.
• W2017552485 hasConcept C120665830 @default.
• W2017552485 hasConcept C121332964 @default.
• W2017552485 hasConcept C126322002 @default.
• W2017552485 hasConcept C142724271 @default.
• W2017552485 hasConcept C143998085 @default.
• W2017552485 hasConcept C151032500 @default.
• W2017552485 hasConcept C167135981 @default.
• W2017552485 hasConcept C2776694085 @default.
• W2017552485 hasConcept C2777586341 @default.
• W2017552485 hasConcept C2778256501 @default.
• W2017552485 hasConcept C2779399171 @default.
• W2017552485 hasConcept C61511704 @default.
• W2017552485 hasConcept C71924100 @default.

• next